Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 9Phase NA 2Phase 1/2 2Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Colonic Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Peripheral Nervous System Diseases 1Neoplasm Metastasis 1

Interventions

Oxaliplatin 11Docetaxel 8Fluorouracil 6Capecitabine 6Leucovorin 5Drug Therapy 5apatinib 4Trastuzumab 4S 1 (combination) 4Tegafur 3Paclitaxel 3Nivolumab 3Irinotecan 3Cisplatin 3sintilimab 2disitamab vedotin 2Surgical Procedures, Operative 2Standard of Care 2Ramucirumab 2Hyperthermic Intraperitoneal Chemotherapy 2Epirubicin 2vinflunine 1toripalimab 1titanium silicide 1tislelizumab 1taxane 1polysaccharide-K 1pertuzumab 1margetuximab 1gimeracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Stomach Neoplasms × XELOX × Clear all
NCT03399253 2018-01-16

Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor

Sun Yat-sen University

Phase 2/3 Unknown
120 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡